Clinical Trials List
2017-10-01 - 2024-11-07
Phase III
Terminated6
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 柯紀綸 Division of General Internal Medicine
- CHENG-HONG TSAI Division of General Internal Medicine
- Chien-Chin Lin Division of General Internal Medicine
- Tai-Chung Huang Division of General Internal Medicine
- SHAN-CHI YU Division of General Internal Medicine
- HSIN-AN HOU Division of General Internal Medicine
- Huai-Hsuan Huang Division of General Internal Medicine
- Shang-Ju Wu Division of General Internal Medicine
- MING YAO Division of General Internal Medicine
- CHIH-WEI YU Division of General Internal Medicine
- 林耘曲 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shih-Feng Cho Division of Hematology & Oncology
- Hui-Hua Hsiao Division of Hematology & Oncology
- Jeng-Shiun Du Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Yao-Chung Liu Division of Hematology & Oncology
- Liang-Tsai Hsiao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
440 participants
